Mesenchymal stem cells as therapeutic vehicles for glioma
Cancer Gene Therapy, Published online: 23 April 2024; doi:10.1038/s41417-024-00775-7Mesenchymal stem cells as therapeutic vehicles for glioma (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - April 23, 2024 Category: Cancer & Oncology Authors: Tomoya Oishi Shinichiro Koizumi Kazuhiko Kurozumi Source Type: research
miR-451a was selectively sorted into exosomes and promoted the progression of esophageal squamous cell carcinoma through CAB39
Cancer Gene Therapy, Published online: 22 April 2024; doi:10.1038/s41417-024-00774-8miR-451a was selectively sorted into exosomes and promoted the progression of esophageal squamous cell carcinoma through CAB39 (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - April 22, 2024 Category: Cancer & Oncology Authors: Lu Wang Huijuan Liu Qinglu Wu Yiqian Liu Zhenpeng Yan Guohui Chen Yao Shang Songrui Xu Qichao Zhou Ting Yan Xiaolong Cheng Source Type: research
Cleavage and polyadenylation machinery as a novel targetable vulnerability for human cancer
Cancer Gene Therapy, Published online: 17 April 2024; doi:10.1038/s41417-024-00770-yCleavage and polyadenylation machinery as a novel targetable vulnerability for human cancer (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - April 17, 2024 Category: Cancer & Oncology Authors: Giulia Pagani Paolo Gandellini Source Type: research
Inhibition of the galactosyltransferase C1GALT1 reduces osteosarcoma cell proliferation by interfering with ERK signaling and cell cycle progression
Cancer Gene Therapy, Published online: 15 April 2024; doi:10.1038/s41417-024-00773-9Inhibition of the galactosyltransferase C1GALT1 reduces osteosarcoma cell proliferation by interfering with ERK signaling and cell cycle progression (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - April 15, 2024 Category: Cancer & Oncology Authors: Kentaro Watanabe Keiji Tasaka Hideto Ogata Shota Kato Hiroo Ueno Katsutsugu Umeda Tomoya Isobe Yasuo Kubota Masahiro Sekiguchi Shunsuke Kimura Aiko Sato-Otsubo Mitsuteru Hiwatari Tetsuo Ushiku Motohiro Kato Akira Oka Satoru Miyano Seishi Ogawa Junko Takit Source Type: research
CRISPR-Cas gene knockouts to optimize engineered T cells for cancer immunotherapy
Cancer Gene Therapy, Published online: 12 April 2024; doi:10.1038/s41417-024-00771-xCRISPR-Cas gene knockouts to optimize engineered T cells for cancer immunotherapy (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - April 12, 2024 Category: Cancer & Oncology Authors: Valentine De Castro Jeanne Galaine Romain Loyon Yann Godet Source Type: research
Correction: SPRTN is involved in hepatocellular carcinoma development through the ER stress response
Cancer Gene Therapy, Published online: 10 April 2024; doi:10.1038/s41417-024-00772-wCorrection: SPRTN is involved in hepatocellular carcinoma development through the ER stress response (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - April 10, 2024 Category: Cancer & Oncology Authors: Anja Batel Mirjana Polovi ć Mateo Glumac Oliver Šuman Stipislav Jadrijevi ć Bernarda Lozi ć Marija Petrovi ć Bobana Samard žija Nicholas J. Bradshaw Karlo Skube Vinko Palada Mislav Acman Ivana Marinovi ć Terzić Source Type: research
Understanding, diagnosing, and treating pancreatic cancer from the perspective of telomeres and telomerase
Cancer Gene Therapy, Published online: 09 April 2024; doi:10.1038/s41417-024-00768-6Understanding, diagnosing, and treating pancreatic cancer from the perspective of telomeres and telomerase (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - April 9, 2024 Category: Cancer & Oncology Authors: Songting Shou Yuanliang Li Jiaqin Chen Xing Zhang Chuanlong Zhang Xiaochen Jiang Fudong Liu Li Yi Xiyuan Zhang En Geer Zhenqing Pu Bo Pang Source Type: research
RevCAR-expressing immune effector cells for targeting of Fn14-positive glioblastoma
Cancer Gene Therapy, Published online: 06 April 2024; doi:10.1038/s41417-024-00766-8RevCAR-expressing immune effector cells for targeting of Fn14-positive glioblastoma (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - April 6, 2024 Category: Cancer & Oncology Authors: Haidy A. Saleh Nicola Mitwasi Liliana R. Loureiro Alexandra Kegler Karla Elizabeth Gonz ález Soto Lydia Hoffmann Eugenia Crespo Claudia Arndt Ralf Bergmann Michael Bachmann Anja Feldmann Source Type: research
SDCBP modulates tumor microenvironment, tumor progression and anti-PD1 efficacy in colorectal cancer
Cancer Gene Therapy, Published online: 30 March 2024; doi:10.1038/s41417-024-00758-8SDCBP modulates tumor microenvironment, tumor progression and anti-PD1 efficacy in colorectal cancer (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - March 30, 2024 Category: Cancer & Oncology Authors: Jiahua Yu Shijun Yu Jin Bai Zhe Zhu Yong Gao Yandong Li Source Type: research
PANoptosis: bridging apoptosis, pyroptosis, and necroptosis in cancer progression and treatment
Cancer Gene Therapy, Published online: 29 March 2024; doi:10.1038/s41417-024-00765-9PANoptosis: bridging apoptosis, pyroptosis, and necroptosis in cancer progression and treatment (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - March 29, 2024 Category: Cancer & Oncology Authors: Jie Gao Anying Xiong Jiliu Liu Xiaolan Li Junyi Wang Lei Zhang Yao Liu Ying Xiong Guoping Li Xiang He Source Type: research
Generation of glioblastoma in mice engrafted with human cytomegalovirus-infected astrocytes
Cancer Gene Therapy, Published online: 29 March 2024; doi:10.1038/s41417-024-00767-7Generation of glioblastoma in mice engrafted with human cytomegalovirus-infected astrocytes (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - March 29, 2024 Category: Cancer & Oncology Authors: Joris Guyon Sandy Haidar Ahmad Ranim El Baba M égane Le Quang Andreas Bikfalvi Thomas Daubon Georges Herbein Source Type: research
Gastrointestinal infections and gastrointestinal haemorrhage are underestimated but serious adverse events in chimeric antigen receptor T-cell recipients: A real-world study
Cancer Gene Therapy, Published online: 28 March 2024; doi:10.1038/s41417-024-00752-0Gastrointestinal infections and gastrointestinal haemorrhage are underestimated but serious adverse events in chimeric antigen receptor T-cell recipients: A real-world study (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - March 28, 2024 Category: Cancer & Oncology Authors: Zhiqiang Song Yang Wang Ping Liu Yuke Geng Na Liu Jie Chen Jianmin Yang Source Type: research
Enhanced epithelial-mesenchymal transition signatures are linked with adverse tumor microenvironment, angiogenesis and worse survival in gastric cancer
Cancer Gene Therapy, Published online: 26 March 2024; doi:10.1038/s41417-024-00756-wEnhanced epithelial-mesenchymal transition signatures are linked with adverse tumor microenvironment, angiogenesis and worse survival in gastric cancer (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - March 26, 2024 Category: Cancer & Oncology Authors: Masanori Oshi Arya Mariam Roy Li Yan Sachika Kinoshita Yuko Tamura Takashi Kosaka Hirotoshi Akiyama Chikara Kunisaki Kazuaki Takabe Itaru Endo Source Type: research
Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications
Cancer Gene Therapy, Published online: 18 March 2024; doi:10.1038/s41417-024-00764-wHeterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - March 18, 2024 Category: Cancer & Oncology Authors: Fatema Safri Romario Nguyen Shadi Zerehpooshnesfchi Jacob George Liang Qiao Source Type: research
Hippo pathway in non-small cell lung cancer: mechanisms, potential targets, and biomarkers
Cancer Gene Therapy, Published online: 18 March 2024; doi:10.1038/s41417-024-00761-zHippo pathway in non-small cell lung cancer: mechanisms, potential targets, and biomarkers (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - March 18, 2024 Category: Cancer & Oncology Authors: Hongge Liang Yan Xu Jing Zhao Minjiang Chen Mengzhao Wang Source Type: research
